This site is intended for healthcare professionals
Blue test tubes arranged in a line, disappearing into the background
  • Home
  • /
  • News
  • /
  • 2011
  • /
  • 11
  • /
  • Nomac-E2 is rejected by FDA as a contraceptive
Drug news

Nomac-E2 is rejected by FDA as a contraceptive

Read time: 1 mins
Last updated: 11th Nov 2011
Published: 11th Nov 2011
Source: Pharmawand
Zoely/Nomac-E2 is a combined contraceptive pill (nomegestrol acetate (a progestogen) and estradiol (an oestrogen) which was approved by EMA for Teva Pharma on 17 July 2011 to be launched by year end and rejected by the FDA for Merck Inc. some days ago.
How do you prefer to access medical updates and information?
CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Related news and insights

Blue test tubes arranged in a line, disappearing into the background
Drug news
Moderna reports H5 Flu data
Moderna’s H5 flu vaccine shows strong immune response in Phase 1/2; HHS ends late-stage funding, new paths explored.
Read more
Drug news
Cibotercept in PAH ends

Published: 30th May 2025

Read more
Drug news
Khindivi cleared for pediatrics

Published: 30th May 2025

Read more
See all news